5. Hypocortisolemic disorders

Key Issues in Mental Health

Volumn 174, Issue , 2008, Pages 60-77

  Fries, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449110412     PISSN: 16624874     EISSN: 16624882     Source Type: Book Series    
DOI: 10.1159/000119047     Document Type: Review

References (103)

1. Chrousos GP, Gold PW: The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
2. Heim C, Ehlert U, Hellhammer DH: The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25: 1-35.
3. Fries E, Hesse J, Hellhammer J, Hellhammer DH: A new view on hypocortisolism. Psychoneuroendocrinology 2005; 30: 1010-1016.
4. Pacak K, McCarty R: Acute stress response: experimental; in Fink G (ed): Encyclopedia of Stress. San Diego, Academic Press, 2000, pp 8-17.
5. Murphy BEP: Glucocorticoids, Overview; in Fink G (ed): Encyclopedia of Stress. San Diego, Academic Press, 2000, pp 244-261.
6. Watkins LR, Maier SF: Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005; 257: 139-155.
7. Franchimont D, Kino T, Galon J, Meduri GU, Chrousos G: Glucocorticoids and inflammation revisited: the state of the art: NIH clinical staff conference. Neuroimmunomodulation 2002; 10: 247-260.
8. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D: Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156: 2406-2412.
9. Kvetnansky R, Fukuhara K, Pacak K, Cizza G, Goldstein DS, Kopin IJ: Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 1993; 133: 1411-1419.
10. Valentino RJ, Page ME, Curtis AL: Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 1991; 555: 25-34.
11. Valentino RJ: CRH effects on central noradrenergic neurons: relationship to stress. Adv Exp Med Biol 1988; 245: 47-64.
12. Lechner SM, Valentino RJ: Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus. Brain Res 1999; 816: 17-28.
13. Hellhammer DH, Wade S: Endocrine correlates of stress vulnerability. Psychother Psychosom 1993; 60: 8-17.
14. Reber SO, Birkeneder L, Veenema AH, Obermeier F, Falk W, Straub RH, Neumann ID: Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 2007; 148: 670-682.
15. Reber SO, Obermeier F, Straub RH, Falk W, Neumann ID: Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice increases the severity of an acute DSS-induced colitis and impairs regeneration. Endocrinology 2006; 147: 4968-4976.
16. Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW: Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 1991; 30: 1031-1048.
17. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER: Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998; 25: 1374-1381.
18. Heim C, Ehlert U, Hanker JP, Hellhammer DH: Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 1998; 60: 309-318.
19. Pruessner JC, Hellhammer DH, Kirschbaum C: Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 1999; 61: 197-204.
20. Gold PW, Chrousos GP: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry 2002; 7: 254-275.
21. Gur A, Cevik R, Nas K, Colpan L, Sarac S: Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 2004; 6:R232-R238.
22. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ: Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 2004; 184: 136-141.
23. Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C: Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004; 55: 745-751.
24. Rohleder N, Wolf JM, Kirschbaum C: Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 2003; 6: 207-222.
25. Chrousos GP, Kino T: Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 2007; 10: 213-219.
26. Ford JD, Campbell KA, Storzbach D, Binder LM, Anger WK, Rohlman DS: Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med 2001; 63: 842-849.
27. Clauw DJ, Chrousos GP: Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997; 4: 134-153.
28. Van Hoof E, Cluydts R, De Meirleir K: Atypical depression as a secondary symptom in chronic fatigue syndrome. Med Hypotheses 2003; 61: 52-55.
29. Antonijevic IA: Depressive disorders - is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31: 1-15.
30. Matza LS, Revicki DA, Davidson JR, Stewart JW: Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 2003; 60: 817-826.
31. Geracioti TD Jr, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT: Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab 1992; 74: 1325-1330.
32. Geracioti TD Jr, Loosen PT, Orth DN: Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry 1997; 42: 165-174.
33. Murck H: Atypical depression spectrum disorder: neurobiology and treatment. Acta Neuropsychiatr 2003; 15: 227-241.
34. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW: Evidence for impaired activation of the hypothalamic-pituitary- adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-1234.
35. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ Jr, May C, Post RM, Chrousos GP, Gold PW: Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab 1991; 72: 260-271.
36. Joseph-Vanderpool JR, Rosenthal NE, Chrousos GP, Wehr TA, Skwerer R, Kasper S, Gold PW: Abnormal pituitary-adrenal responses to corticotropin- releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. J Clin Endocrinol Metab 1991; 72: 1382-1387.
37. Wessely S, Nimnuan C, Sharpe M: Functional somatic syndromes: one or many? Lancet 1999; 354: 936-939.
38. Dunn AJ, Swiergiel AH, Palamarchouk V: Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann NY Acad Sci 2004; 1018: 25-34.
39. Berridge CW, Waterhouse BD: The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003; 42: 33-84.
40. Roth T, Roehrs T, Pies R: Insomnia: pathophysiology and implications for treatment. Sleep Med Rev 2007; 11: 71-79.
41. Yehuda R: Biology of posttraumatic stress disorder. J Clin Psychiatry 2001; 62(suppl 17):41-46.
42. Rupprecht M, Salzer B, Raum B, Hornstein OP, Koch HU, Riederer P, Sofic E, Rupprecht R: Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls. Exp Clin Endocrinol Diabetes 1997; 105: 39-45.
43. Buske-Kirschbaum A, Geiben A, Hollig H, Morschhauser E, Hellhammer D: Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 2002; 87: 4245-4251.
44. Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ: Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J Psychosom Res 2006; 60: 145-153.
45. Racciatti D, Guagnano MT, Vecchiet J, De Remigis PL, Pizzigallo E, Della Vecchia R, Di Sciascio T, Merlitti D, Sensi S: Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. Int J Immunopathol Pharmacol 2001; 14: 11-15.
46. Jerjes WK, Taylor NF, Wood PJ, Cleare AJ: Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 2007; 32(2):192-198.
47. Gaab J, Huster D, Peisen R, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U: Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom Med 2002; 64: 951-962.
48. Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ: Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 1998; 43: 236-237.
49. Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A, Wessely S: Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37: 245-252.
50. Tops M, van Peer JM, Wijers AA, Korf J: Acute cortisol administration reduces subjective fatigue in healthy women. Psychophysiology 2006; 43: 653-656.
51. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V: Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001; 86: 3545-3554.
52. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE: Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. Jama 1998; 280: 1061-1066.
53. Kasckow JW, Baker D, Geracioti TD Jr: Corticotropin-releasing hormone in depression and posttraumatic stress disorder. Peptides 2001; 22: 845-851.
54. Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH: Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 2002; 27: 47-51.
55. Bouwer C, Claassen J, Dinan TG, Nemeroff CB: Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. Depress Anxiety 2000; 12: 44-50.
56. Dinan TG, Lavelle E, Cooney J, Burnett F, Scott L, Dash A, Thakore J, Berti C: Dexamethasone augmentation in treatment-resistant depression. Acta Psychiatr Scand 1997; 95: 58-61.
57. Konsman JP, Parnet P, Dantzer R: Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002; 25: 154-159.
58. Patarca R: Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 2001; 933: 185-200.
59. Meeus M, Nijs J, Meirleir KD: Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J Pain 2006.
60. Asmundson GJ, Coons MJ, Taylor S, Katz J: PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry 2002; 47: 930-937.
61. Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER: Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 1997; 22: 603-614.
62. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitaryadrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583-1592.
63. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA: Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004; 18: 314-325.
64. Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL: Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106: 534-543.
65. Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S: Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 1998; 98: 328-335.
66. Wingenfeld K, Wagner D, Schmidt I, Meinlschmidt G, Hellhammer DH, Heim C: The low-dose dexamethasone suppression test in fibromyalgia. J Psychosom Res 2007; 62: 85-91.
67. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F: Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett 1997; 237: 65-68.
68. Bohmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U: Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005; 67: 288-294.
69. Klingmann PO, Kugler I, Steffke TS, Bellingrath S, Kudielka BM, Hellhammer DH: Sex-specific programming: a risk for fibromyalgia. Ann NY Acad Sci; submitted.
70. Entringer S: Exposure to Prenatal Psychosocial Stress: Implications for Long-Term Disease Susceptibility. Göttingen, Cuvillier, 2007.
71. Buss C, Lord C, Wadiwalla M, Hellhammer DH, Lupien SJ, Meaney MJ, Pruessner JC: Maternal care modulates the relationship between prenatal risk and hippocampal volume in women but not in men. J Neurosci 2007; 27: 2592-2595.
72. Samad TA, Sapirstein A, Woolf CJ: Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 2002; 8: 390-396.
73. Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-328.
74. Salerno A, Hermann R: Efficacy and safety of steroid use for postoperative pain relief: update and review of the medical literature. J Bone Joint Surg Am 2006; 88: 1361-1372.
75. Santini G, Patrignani P, Sciulli MG, Seta F, Tacconelli S, Panara MR, Ricciotti E, Capone ML, Patrono C: The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids. Clin Pharmacol Ther 2001; 70: 475-483.
76. Wieseler-Frank J, Maier SF, Watkins LR: Central proinflammatory cytokines and pain enhancement. Neurosignals 2005; 14: 166-174.
77. Miller GE, Chen E, Zhou ES: If it goes up, must it come down? Chronic stress and the hypothalamicpituitary-adrenocortical axis in humans. Psychol Bull 2007; 133: 25-45.
78. Houshyar H, Cooper ZD, Woods JH: Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. J Neuroendocrinol 2001; 13: 862-874.
79. Houshyar H, Galigniana MD, Pratt WB, Woods JH: Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 2001; 13: 875-886.
80. Houshyar H, Gomez F, Manalo S, Bhargava A, Dallman MF: Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 2003; 28: 1960-1972.
81. Wust S, Federenko IS, van Rossum EF, Koper JW, Hellhammer DH: Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors. Psychoneuroendocrinology 2005; 30: 199-211.
82. Kirschbaum C, Wust S, Faig HG, Hellhammer DH: Heritability of cortisol responses to human corticotropin-releasing hormone, ergometry, and psychological stress in humans. J Clin Endocrinol Metab 1992; 75: 1526-1530.
83. Wust S, Federenko I, Hellhammer DH, Kirschbaum C: Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000; 25: 707-720.
84. Segman RH, Shalev AY: Genetics of posttraumatic stress disorder. CNS Spectr 2003; 8: 693-698.
85. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr: Family study of fibromyalgia. Arthritis Rheum 2004; 50: 944-952.
86. Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW, Chrousos GP: Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin Endocrinol Metab 2004; 89: 2228-2236.
87. Muller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, Holsboer F, Uhr M: ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 2003; 28: 1991-1999.
88. Wust S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH: Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004; 89: 565-573.
89. Welberg LA, Seckl JR, Holmes MC: Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001; 104: 71-79.
90. Fameli M, Kitraki E, Stylianopoulou F: Effects of hyperactivity of the maternal hypothalamic-pituitary-adrenal (HPA) axis during pregnancy on the development of the HPA axis and brain monoamines of the offspring. Int J Dev Neurosci 1994; 12: 651-659.
91. Kajantie E, Phillips DI, Andersson S, Barker DJ, Dunkel L, Forsen T, Osmond C, Tuominen J, Wood PJ, Eriksson J: Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism? Clin Endocrinol (Oxf) 2002; 57: 635-641.
92. Kajantie E, Eriksson J, Barker DJ, Forsen T, Osmond C, Wood PJ, Andersson S, Dunkel L, Phillips DI: Birthsize, gestational age and adrenal function in adult life: studies of dexamethasone suppression and ACTH1-24 stimulation. Eur J Endocrinol 2003; 149: 569-575.
93. Ducsay CA: Fetal and maternal adaptations to chronic hypoxia: prevention of premature labor in response to chronic stress. Comp Biochem Physiol [A] 1998; 119: 675-681.
94. Yehuda R, Engel SM, Brand SR, Seckl J, Marcus SM, Berkowitz GS: Transgenerational effects of post-traumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005; 90: 4115-4118.
95. Meaney MJ: Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Ann Rev Neurosci 2001; 24: 1161-1192.
96. De Bellis MD, Chrousos GP, Dorn LD, Burke L, Helmers K, Kling MA, Trickett PK, Putnam FW: Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab 1994; 78: 249-255.
97. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB: Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001; 158: 575-581.
98. Bremner JD, Vythilingam M, Anderson G, Vermetten E, McGlashan T, Heninger G, Rasmusson A, Southwick SM, Charney DS: Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol Psychiatry 2003; 54: 710-718.
99. Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, Unger ER, Reeves WC: Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry 2006; 63: 1258-1266.
100. McEwen BS, Stellar E: Stress and the individual: mechanisms leading to disease. Arch Intern Med 1993; 153: 2093-2101.
101. McEwen BS, Wingfield JC: The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43: 2-15.
102. Hellhammer J, Schlotz W, Stone AA, Pirke KM, Hellhammer D: Allostatic load, perceived stress, and health: a prospective study in two age groups. Ann NY Acad Sci 2004; 1032: 8-13.
103. Raison CL, Miller AH: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160: 1554-1565.